Yep, I'm having a hard time keeping up w/ the whipsaw call/put action.
________________________________
There is a little black spot on the sun today
Recent VTRS News
- U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain • PR Newswire (US) • 05/18/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:30:24 PM
- Viatris to Present at the Bank of America Securities 2026 Healthcare Conference • PR Newswire (US) • 05/07/2026 08:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:03:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 11:47:46 AM
- Viatris Reports First-Quarter 2026 Financial Results • PR Newswire (US) • 05/07/2026 10:59:00 AM
- Viatris Announces Quarterly Dividend • PR Newswire (US) • 05/05/2026 10:59:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 08:39:32 PM
- Viatris Announces Chief Financial Officer Transition • PR Newswire (US) • 05/04/2026 08:30:00 PM
- Viatris Announces Several Data Presentations on Investigational Low-Dose Estrogen Combined Hormonal Contraceptive Weekly Patch at the 2026 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting • PR Newswire (US) • 05/01/2026 10:59:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 06:24:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/16/2026 10:00:28 PM
- Viatris to Report First Quarter 2026 Financial Results on May 7, 2026 • PR Newswire (US) • 04/13/2026 10:59:00 AM
- Viatris Announces Multiple Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting • PR Newswire (US) • 04/10/2026 10:59:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/02/2026 08:31:39 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/02/2026 08:30:52 PM
- Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD) • PR Newswire (US) • 03/23/2026 10:59:00 AM
- Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030 • PR Newswire (US) • 03/19/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 11:04:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 11:03:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 12:00:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 12:00:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 12:00:16 AM
